Posts in category Business Standard
Remsons Industries consolidated net profit rises 101.96% in the March 2024 quarter (29-05-2024)
Sales rise 5.97% to Rs 81.00 crore
Almondz Global Securities consolidated net profit rises 48.88% in the March 2024 quarter (29-05-2024)
Sales rise 70.52% to Rs 45.41 crore
Foreign funds return to Indian bonds as JPMorgan index inclusion nears (29-05-2024)
Overseas investors bought about $358 million of bonds on Monday, the most in two months and a seventh successive day of purchases, data compiled by Bloomberg show
Gangotri Textiles reports standalone net loss of Rs 0.02 crore in the March 2024 quarter (29-05-2024)
Reported sales nil
Som Datt Finance Corporation reports standalone net profit of Rs 2.74 crore in the March 2024 quarter (29-05-2024)
Sales reported at Rs 3.62 crore
J A Finance reports standalone net profit of Rs 0.34 crore in the March 2024 quarter (29-05-2024)
Sales rise 54.55% to Rs 0.68 crore
Samkrg Pistons & Rings standalone net profit rises 123.11% in the March 2024 quarter (29-05-2024)
Sales rise 22.60% to Rs 65.58 crore
Maris Spinners reports standalone net loss of Rs 0.19 crore in the March 2024 quarter (29-05-2024)
Sales decline 12.39% to Rs 37.75 crore
Intellect Design Arena launches two AI-powered platforms – iCPX and iAPX (29-05-2024)
Intellect Design Arena announced the launch of two cutting-edge AI-powered platforms: iCPX (Corporate Procurement eXchange) and iAPX (Accounts Payable eXchange) using eMACH.ai, the largest, most comprehensive and innovative open finance platform. These revolutionary platforms apply 'First Principles' Thinking along with embedded GenAI from Intellect's own Purple Fabric AI platform to extend Intellect's presence in the Commerce ecosystem by transforming procurement and accounts payable operations for large and mid-sized enterprises.
Mankind Pharma Ltd spurts 1.53%, rises for third straight session (29-05-2024)
Mankind Pharma Ltd is quoting at Rs 2146.8, up 1.53% on the day as on 12:49 IST on the NSE. The stock is up 58.32% in last one year as compared to a 22.34% gain in NIFTY and a 53.84% gain in the Nifty Pharma index.